Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodents.

Rohrbach KW, Han S, Gan J, O'Tanyi EJ, Zhang H, Chi CL, Taub R, Largent BL, Cheng D.

Eur J Pharmacol. 2005 Mar 21;511(1):31-41.

PMID:
15777777
2.

Immunohistochemical visualization of corticotropin-releasing factor type 1 (CRF1) receptors in monkey brain.

Kostich WA, Grzanna R, Lu NZ, Largent BL.

J Comp Neurol. 2004 Oct 11;478(2):111-25.

PMID:
15349973
3.

Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics.

Lee T, Robichaud AJ, Boyle KE, Lu Y, Robertson DW, Miller KJ, Fitzgerald LW, McElroy JF, Largent BL.

Bioorg Med Chem Lett. 2003 Feb 24;13(4):767-70.

PMID:
12639577
4.

Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.

Fitzgerald LW, Burn TC, Brown BS, Patterson JP, Corjay MH, Valentine PA, Sun JH, Link JR, Abbaszade I, Hollis JM, Largent BL, Hartig PR, Hollis GF, Meunier PC, Robichaud AJ, Robertson DW.

Mol Pharmacol. 2000 Jan;57(1):75-81.

PMID:
10617681
5.

High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.

Fitzgerald LW, Conklin DS, Krause CM, Marshall AP, Patterson JP, Tran DP, Iyer G, Kostich WA, Largent BL, Hartig PR.

J Neurochem. 1999 May;72(5):2127-34.

6.

Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.

Fitzgerald LW, Patterson JP, Conklin DS, Horlick R, Largent BL.

J Pharmacol Exp Ther. 1998 Nov;287(2):448-56.

PMID:
9808667
7.

Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor.

Kostich WA, Chen A, Sperle K, Largent BL.

Mol Endocrinol. 1998 Aug;12(8):1077-85.

PMID:
9717834
8.

Characterization of [125I]sauvagine binding to CRH2 receptors: membrane homogenate and autoradiographic studies.

Rominger DH, Rominger CM, Fitzgerald LW, Grzanna R, Largent BL, Zaczek R.

J Pharmacol Exp Ther. 1998 Jul;286(1):459-68.

PMID:
9655891
9.

PTP NE-6: a brain-enriched receptor-type protein tyrosine phosphatase with a divergent catalytic domain.

Fitzgerald LR, Walton KM, Dixon JE, Largent BL.

J Neurochem. 1997 May;68(5):1820-9.

10.

Rapid generation of stable cell lines expressing corticotropin-releasing hormone receptor for drug discovery.

Horlick RA, Sperle K, Breth LA, Reid CC, Shen ES, Robbins AK, Cooke GM, Largent BL.

Protein Expr Purif. 1997 Apr;9(3):301-8.

PMID:
9126600
11.

A goldfish Notch-3 homologue is expressed in neurogenic regions of embryonic, adult, and regenerating brain and retina.

Sullivan SA, Barthel LK, Largent BL, Raymond PA.

Dev Genet. 1997;20(3):208-23. Erratum in: Dev Genet 1997;21(2):175-6.

12.

A novel receptor-type protein tyrosine phosphatase is expressed during neurogenesis in the olfactory neuroepithelium.

Walton KM, Martell KJ, Kwak SP, Dixon JE, Largent BL.

Neuron. 1993 Aug;11(2):387-400.

13.

Directed expression of an oncogene to the olfactory neuronal lineage in transgenic mice.

Largent BL, Sosnowski RG, Reed RR.

J Neurosci. 1993 Jan;13(1):300-12.

14.

Receptor mechanisms in antipsychotic drug action: focus on sigma receptors.

Snyder SH, Largent BL.

J Neuropsychiatry Clin Neurosci. 1989 Winter;1(1):7-15. Review.

PMID:
2577720
15.

Novel antipsychotic drugs share high affinity for sigma receptors.

Largent BL, Wikström H, Snowman AM, Snyder SH.

Eur J Pharmacol. 1988 Oct 18;155(3):345-7. No abstract available.

PMID:
2906878
16.

G protein mRNA mapped in rat brain by in situ hybridization.

Largent BL, Jones DT, Reed RR, Pearson RC, Snyder SH.

Proc Natl Acad Sci U S A. 1988 Apr;85(8):2864-8.

17.

Structural determinants of sigma receptor affinity.

Largent BL, Wikström H, Gundlach AL, Snyder SH.

Mol Pharmacol. 1987 Dec;32(6):772-84.

PMID:
2826991
18.

Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.

D'Amato RJ, Largent BL, Snowman AM, Snyder SH.

J Pharmacol Exp Ther. 1987 Jul;242(1):364-71.

PMID:
3475452
19.

Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas.

D'Amato RJ, Blue ME, Largent BL, Lynch DR, Ledbetter DJ, Molliver ME, Snyder SH.

Proc Natl Acad Sci U S A. 1987 Jun;84(12):4322-6.

20.

Phencyclidine (PCP) receptors: autoradiographic localization in brain with the selective ligand, [3H]TCP.

Gundlach AL, Largent BL, Snyder SH.

Brain Res. 1986 Oct 29;386(1-2):266-79.

PMID:
3022881
23.

Sigma receptors on NCB-20 hybrid neurotumor cells labeled with (+)[3H]SKF 10,047 and (+)[3H]3-PPP.

Largent BL, Gundlach AL, Snyder SH.

Eur J Pharmacol. 1986 May 13;124(1-2):183-7.

PMID:
3013658
24.

Characterization of phencyclidine and sigma receptor-binding sites in brain.

Gundlach AL, Largent BL, Snyder SH.

NIDA Res Monogr. 1986;64:1-13. No abstract available.

PMID:
3012343
25.

Phencyclidine and sigma opiate receptors in brain: biochemical and autoradiographical differentiation.

Gundlach AL, Largent BL, Snyder SH.

Eur J Pharmacol. 1985 Jul 31;113(3):465-6. No abstract available.

PMID:
2995073
26.

125I-Spiperone: a novel ligand for D2 dopamine receptors.

Gundlach AL, Largent BL, Snyder SH.

Life Sci. 1984 Nov 5;35(19):1981-8.

PMID:
6149442
27.

Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

Largent BL, Gundlach AL, Snyder SH.

Proc Natl Acad Sci U S A. 1984 Aug;81(15):4983-7.

28.

Carbohydrate-specific adhesion of alveolar macrophages to mannose-derivatized surfaces.

Largent BL, Walton KM, Hoppe CA, Lee YC, Schnaar RL.

J Biol Chem. 1984 Feb 10;259(3):1764-9.

29.

A unitary mechanism of calcium antagonist drug action.

Murphy KM, Gould RJ, Largent BL, Snyder SH.

Proc Natl Acad Sci U S A. 1983 Feb;80(3):860-4.

Supplemental Content

Loading ...
Support Center